Two Sigma Securities’s KaloBios Pharmaceuticals KBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding KBIO
Two Sigma Securities's KBIO Position: Q2 2015 in Review
Two Sigma Securities sold out of KaloBios Pharmaceuticals (KBIO) in Q2 2015, closing a stake of 5,367 shares — an estimated $21K sold.
Two Sigma Securities first reported a position in KBIO in Q1 2015 and held it in 1 quarter. The position peaked at $21K in Q1 2015. 19 funds tracked by Wall St. Rank hold KBIO as of Q2 2015.
- Two Sigma Securities reported no remaining KaloBios Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
- Two Sigma Securities sold 5,367 KaloBios Pharmaceuticals shares in Q2 2015, an estimated $21K.
- Two Sigma Securities first reported a position in KaloBios Pharmaceuticals in Q1 2015 and held it in 1 quarter.
- Two Sigma Securities's KaloBios Pharmaceuticals position peaked at $21K in Q1 2015.
- 19 funds tracked by Wall St. Rank held KaloBios Pharmaceuticals as of Q2 2015.
Based on Two Sigma Securities's 13F filing for Q2 2015, filed 14 Aug 2015.